Showing results (121-130 of 315) with videos related to

Sort By:
Pageof 32
Biodata Mining|June 26, 2026
Learning a distance for the clustering of patients with amyotrophic lateral sclerosisGuillaume Tejedor Y Dominguez, Hugo Alarcan, Veronika Peralta, et al.
Expert Opinion on Therapeutic Targets|June 2, 2022
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic targetYara Al Ojaimi, Audrey Dangoumau, Hugo Alarcan, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|November 30, 2010
Influence of patients' emotional state on the recovery processes after a transient global amnesiaAudrey Noël, Peggy Quinette, Jacques Dayan, et al.
Medicine|January 27, 2015
Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case seriesMathilde Duchesne, Stéphane Mathis, Philippe Corcia, et al.
Brain : a Journal of Neurology|May 30, 2009
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's diseaseMarine Fouquet, Béatrice Desgranges, Brigitte Landeau, et al.
Brain : a Journal of Neurology|August 7, 2010
Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's diseaseNicolas Villain, Marine Fouquet, Jean-Claude Baron, et al.
Neurocase|April 5, 2005
FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairmentGaël Chételat, Francis Eustache, Fausto Viader, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 2, 2008
Psychopathological factors, memory disorders and transient global amnesiaAudrey Noël, Peggy Quinette, Bérengère Guillery-Girard, et al.
Case Reports in Neurological Medicine|January 4, 2017
Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic SyndromeStéphane Mathis, Laurent Magy, Philippe Corcia, et al.
Expert Opinion on Drug Discovery|January 22, 2026
The preclinical discovery and development of edaravone for the treatment of amyotrophic lateral sclerosis: what lessons have we learnt?Tifenn Charbonnel, Elodie Richard, Adrien Dupuis, et al.
Pageof 32